AstraZeneca

OTC: AZNCF · Real-Time Price · USD
157.80
-2.66 (-1.66%)
At close: Aug 20, 2025, 3:52 PM
160.46
1.69%
After-hours: Aug 19, 2025, 04:00 PM EDT

AstraZeneca Revenue

AstraZeneca reported an annual revenue of $54.07B, reflecting a 18.03% growth. For the quarter ending June 30, 2025, AstraZeneca generated $14.46B in revenue.
Revenue (ttm)
54.07B
Revenue Growth
18.03%
Price / Sales Ratio
3.73
Revenue / Employee
573.41K
Employees
94,300
Market Cap
244.63B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 54.07B +18.03%
Dec 31, 2023 45.81B +3.29%
Dec 31, 2022 44.35B +18.53%
Dec 31, 2021 37.42B +40.58%
Dec 31, 2020 26.62B +9.16%
Dec 31, 2019 24.38B +10.38%
Dec 31, 2018 22.09B -1.67%
Dec 31, 2017 22.46B -2.33%
Dec 31, 2016 23B -6.90%
Dec 31, 2015 24.71B -5.32%
Dec 31, 2014 26.09B +1.49%
Dec 31, 2013 25.71B -8.09%
Dec 31, 2012 27.97B -16.72%
Dec 31, 2011 33.59B +0.97%
Dec 31, 2010 33.27B +1.42%
Dec 31, 2009 32.8B +3.81%
Dec 31, 2008 31.6B +6.91%
Dec 31, 2007 29.56B +11.65%
Dec 31, 2006 26.48B +10.54%
Dec 31, 2005 23.95B +11.78%
Dec 31, 2004 21.43B +13.67%
Dec 31, 2003 18.85B +5.60%
Dec 31, 2002 17.85B -24.27%
Dec 31, 2001 23.57B +30.11%
Dec 31, 2000 18.12B -1.74%
Dec 31, 1999 18.44B +101.57%
Dec 31, 1998 9.15B +6.52%
Dec 31, 1997 8.59B -6.51%
Dec 31, 1996 9.18B +21.35%
Dec 31, 1995 7.57B +8.06%
Dec 31, 1994 7B +6.64%
Dec 31, 1993 6.57B +8.83%
Dec 31, 1992 6.03B -17.91%
Dec 31, 1991 7.35B +0.04%
Dec 31, 1990 7.35B n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.